Literature DB >> 5073941

Clear-cell adenocarcinoma of the cervix after maternal treatment with synthetic estrogens.

K L Noller, D G Decker, A P Lanier, L T Kurland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5073941

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  6 in total

Review 1.  The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.

Authors:  Monica M Laronda; Kenji Unno; Lindsey M Butler; Takeshi Kurita
Journal:  Differentiation       Date:  2012-06-06       Impact factor: 3.880

2.  Genital tract anomalies and cancer in females exposed in utero to diethylstilbestrol. Brief report on the DESAD project.

Authors:  M A Sestili
Journal:  Public Health Rep       Date:  1977 Sep-Oct       Impact factor: 2.792

3.  Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.

Authors:  R J Kurman
Journal:  West J Med       Date:  1979-12

4.  Varying Susceptibility of the Female Mammary Gland to In Utero Windows of BPA Exposure.

Authors:  Andrea R Hindman; Xiaokui Molly Mo; Hannah L Helber; Claire E Kovalchin; Nanditha Ravichandran; Alina R Murphy; Abigail M Fagan; Pamela M St John; Craig J Burd
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

Review 5.  Upper genital tract abnormalities in the Syrian hamster as a result of in utero exposure to diethylstilbestrol. I. Uterine cystadenomatous papilloma and hypoplasia.

Authors:  J Gilloteaux; R J Paul; A W Steggles
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

6.  Clear cell adenocarcinoma of the vagina and cervix in black females.

Authors:  G A Johnston; D Anderson; A L Herbst; M M Hubby
Journal:  J Natl Med Assoc       Date:  1982-07       Impact factor: 1.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.